Role of Orexin-B/Orexin 2 receptor in myocardial protection
Tóm tắt
Emerging evidence attributes to orexins/hypocretins (ORs) a protective function in the regulation of cardiovascular responses, heart rate, and hypertension. However, little is known about any direct effect of orexins in the heart function. This is of special relevance considering that cardiovascular diseases, including myocardial infarction and heart failure, are one of the major causes of mortality in the world. In the article published in Clinical Science (2018) (vol. 132, 2547–2564), Patel and colleagues investigated the role of orexins in myocardial protection. Intriguingly, they revealed a source of orexin-A (OR-A) and orexin-B (OR-B) in the heart and cardiomyocytes of the rat. More interestingly, these peptides exert a direct effect on the heart rate by acting in an autocrine/paracrine manner on their respective receptors (OXRs). Indeed, OR-B, but not OR-A, by acting through orexin receptor-2 (OX2R), exerts direct cardioprotective effects in heart failure models. OR-B/OX2R signalling enhances myosin light chain (MLC) and troponin-I (TnI) phosphorylation in a dose-dependent manner, leading to an increase in the strength of their twitch contraction. This effect is mediated by extracellular signal-regulated kinase 1/2 (ERK1/2) and Akt phosphorylation, both in the rat myocardial tissue and human heart samples. A negative correlation between OX2R expression and clinical severity of symptoms has been found in patients with heart failure. Thus, in addition to the known central effects of orexins/OX2R, the work of Patel and colleagues (Clinical Science (2018) 132, 2547–2564) reports a direct action of OR-B on the heart rate pinpointing to OX2R as a potential therapeutic target for prevention and treatment of cardiovascular disease.
Từ khóa
Tài liệu tham khảo
de Lecea, 1998, The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity, Proc. Natl. Acad. Sci. U.S.A., 95, 322, 10.1073/pnas.95.1.322
Sakurai, 1998, Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior, Cell, 92, 573, 10.1016/S0092-8674(00)80949-6
Smart, 1999, Characterization of recombinant human orexin receptor pharmacology in a Chinese hamster ovary cell-line using FLIPR, Br. J. Pharmacol., 128, 1, 10.1038/sj.bjp.0702780
Smart, 2000, The hypocretins are weak agonists at recombinant human orexin-1 and orexin-2 receptors, Br. J. Pharmacol., 129, 1289, 10.1038/sj.bjp.0703257
Imperatore, 2007, Role of Orexin-A in hypertension and obesity, Curr. Hypertens. Rep., 19, 34, 10.1007/s11906-017-0729-y
Samson, 1999, Cardiovascular regulatory actions of the hypocretins in brain, Brain Res., 831, 248, 10.1016/S0006-8993(99)01457-2
Shirasaka, 1999, Sympathetic and cardiovascular actions of orexins in conscious rats, Am. J. Physiol., 277, R1780
Mozaffarian, 2015, Heart disease and stroke statistics-2015 update: a report from the American Heart Association, Circulation, 131, e29
Townsend, 2015, Cardiovascular disease in Europe 2015: epidemiological update, Eur. Heart J., 36, 2673, 10.1093/eurheartj/ehv428
Matsumura, 2001, Central orexin-A augments sympathoadrenal out flow in conscious rabbits, Hypertension, 37, 1382, 10.1161/01.HYP.37.6.1382
Huang, 2010, Orexins depolarize rostral ventrolateral medulla neurons and increase arterial pressure and heart rate in rats mainly via orexin 2 receptors, J. Pharmacol. Exp. Ther., 334, 522, 10.1124/jpet.110.167791
Date, 1999, Orexins, orexigenic hypothalamic peptides, interact with autonomic, neuroendocrine and neuroregulatory systems, Proc. Natl. Acad. Sci. U.S.A., 96, 748, 10.1073/pnas.96.2.748
Allen, 2002, Inhibition of the hypothalamic paraventricular nucleus in spontaneously hypertensive rats dramatically reduces sympathetic vasomotor tone, Hypertension, 39, 275, 10.1161/hy0202.104272
Li, 2007, Glutamatergic inputs in the hypothalamic paraventricular nucleus maintain sympathetic vasomotor tone in hypertension, Hypertension, 49, 916, 10.1161/01.HYP.0000259666.99449.74
Shahid, 2011, Intrathecal orexin a increases sympathetic outflow and respiratory drive, enhances baroreflex sensitivity and blocks the somato-sympathetic reflex, Br. J. Pharmacol., 162, 961, 10.1111/j.1476-5381.2010.01102.x
Peyron, 1998, Neurons containing hypocretin (orexin) project to multiple neuronal systems, J. Neurosci., 18, 9996, 10.1523/JNEUROSCI.18-23-09996.1998
Shirasaka, 2002, Neuronal effects of orexins: relevant to sympathetic and cardiovascular functions, Regul. Pept., 104, 91, 10.1016/S0167-0115(01)00352-4
Shahid, 2012, Orexin and central regulation of cardiorespiratory system, Vitam. Horm., 89, 159, 10.1016/B978-0-12-394623-2.00009-3
Shirasaka, 2003, Cardiovascular effects of leptin and orexins, Am. J. Physiol. Regul. Integr. Comp. Physiol., 284, R639, 10.1152/ajpregu.00359.2002
Marcus, 2001, Differential expression of orexin receptors 1 and 2 in the rat brain, J. Comp. Neurol., 435, 6, 10.1002/cne.1190
Hagan, 1999, Orexin A activates locus coeruleus cell firing and increases arousal in the rat, Proc. Natl. Acad. Sci. U.S.A., 96, 10911, 10.1073/pnas.96.19.10911
Horvath, 1999, Hypocretin (orexin) activation and synaptic innervation of the locus coeruleus noradrenergic system, J. Comp. Neurol., 415, 145, 10.1002/(SICI)1096-9861(19991213)415:2%3c145::AID-CNE1%3e3.0.CO;2-2
van den Pol, 2002, Hypocretin (orexin) enhances neuron activity and cell synchrony in developing mouse GFP-expressing locus coeruleus, J. Physiol., 541, 169, 10.1113/jphysiol.2002.017426
Chen, 2008, Reinvestigation of the effect of orexin A on catecholamine release from adrenal chromaffin cells, Neurosci. Lett., 436, 181, 10.1016/j.neulet.2008.03.014
Puskás, 2010, Interactions between orexin-immunoreactive fibers and adrenaline or noradrenaline-expressing neurons of the lower brainstem in rats and mice, Peptides, 31, 1589, 10.1016/j.peptides.2010.04.020
Bochorishvili, 2014, The orexinergic neurons receive synaptic input from C1 cells in rats, J. Comp. Neurol., 522, 3834, 10.1002/cne.23643
Li, 2013, Antagonism of orexin receptors significantly lowers blood pressure in spontaneously hypertensive rats, J. Physiol., 591, 4237, 10.1113/jphysiol.2013.256271
Patel, 2018, Functional cardiac orexin receptors: role of orexin-B/orexin 2 receptor in myocardial protection, Clin. Sci. (Lond.), 132, 2547, 10.1042/CS20180150
Bose, 2007, Myocardial ischaemia-reperfusion injury is attenuated by intact glucagon like peptide-1 (GLP-1) in the in vitro rat heart and may involve the p70s6K pathway, Cardiovasc. Drugs Ther., 21, 253, 10.1007/s10557-007-6030-6
Bopassa, 2010, A novel estrogen receptor GPER inhibits mitochondria permeability transition pore opening and protects the heart against ischemia-reperfusion injury, Am. J. Physiol. Heart Circ. Physiol., 298, H16, 10.1152/ajpheart.00588.2009
Carrive, 2017, Orexin and central modulation of cardiovascular and respiratory function, Curr. Top. Behav. Neurosci., 33, 157, 10.1007/7854_2016_46